Rare diseases
Investigational molecules
Locations
Back to Germany4 clinical trials in Friedrichsthal, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research investigating the combined effects of baxdrostat and dapagliflozin in patients with concurrent chronic kidney disease and hypertension. This study aims to evaluate treatment outcomes and safety profiles in adult patients.
The research focuses on preventing kidney failure and reducing cardiovascular mortality rates.
Comparative research examining tirzepatide against dulaglutide for major cardiovascular outcomes in Type 2 Diabetes patients. The study evaluates cardiovascular safety and efficacy endpoints.
This research aims to advance treatment options for diabetes patients with high cardiovascular risk.
Investigation of orforglipron in treating patients with combined obesity and Type 2 Diabetes. The study focuses on weight management outcomes and metabolic improvements.
Comprehensive evaluation of dual-action treatment approaches for weight and glycemic control.
Long-term study examining semaglutide's effects on diabetic retinopathy progression compared to placebo in Type 2 Diabetes patients.
This research aims to understand the relationship between diabetes treatment and eye health outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
